Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO
03/10/2025 07:25
Oct 3 (Reuters) - OSE Immunotherapeutics SA OSE.PA: APPOINTMENT OF MARC LE BOZEC AS INTERIM CEO Source text: ID:nGNXbC13qh Further company coverage: OSE.PA ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO